What's New in Developmental and Epileptic Encephalopathies Webinar
Epilepsy
Epilepsy Research Matters: Genetic treatment for CDKL5 Deficiency Disorder
The Epilepsy Research Institute's Research Programme
New approaches in epilepsy research
COMMENTS
Epilepsy research in 2022: clinical advances
In 2022, epilepsy research has made advances across a range of clinically important areas, from self-management, genetics, imaging, and surgical planning to understanding febrile seizures and coma-related periodic patterns. Most notably, in May 2022, the World Health Assembly adopted the Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders, which aims to address gaps ...
Epilepsy Research News -- ScienceDaily
May 29, 2024 — While older drugs for epilepsy, taken while pregnant, have been shown in previous research to affect the creative thinking of children, a new study finds no effects on creativity ...
Largest genetic study of epilepsy to date provides new ...
The research, published today in Nature Genetics, greatly advances our knowledge of why epilepsy develops and may inform the development of new treatments for the condition.. Epilepsy, a common ...
Major advances in epilepsy research in 2023
With great anticipation, 2023 has seen many important advances in epilepsy research. Noteworthy progress has been achieved in understanding the intricate mechanisms of epilepsy, accompanied by important strides in developing new therapies.
New epilepsy therapies in development
Epilepsy is one of the most common and disabling brain disorders, affecting approximately 1% of the population of all ages 1, equating to ~3.3 million people in the USA and 70 million worldwide ...
New drug offers relief for treatment-resistant epilepsy patients
In cases where standard therapies fail, a medication called XEN1101 reduces seizure frequency by more than 50% in some patients and sometimes eliminates them altogether, a new study shows. Unlike ...
Stanford Medicine-led study identifies novel target for epilepsy
Researchers find that a little-understood part of the brain appears to be involved in starting seizures and keeping them going. April 17, 2024 - By Kimberlee D'Ardenne
New tech gives hope for a million people with epilepsy
New Tech Targets Epileptic Seizures With Lasers, Robots And Precision Surgery : Short Wave About three million people in the United States have epilepsy, including about a million who can't rely ...
Epilepsy
Epilepsy refers to a group of neurological disorders of varying aetiology, characterized by recurrent brain dysfunction that result from sudden excessive and disordered neuronal discharge. These ...
From precision diagnosis to precision treatment in epilepsy
The new study, performed by Dianalee McKnight and colleagues and published in JAMA Neurology, included 418 participants with epilepsy who received a genetic diagnosis between the ages of 0 and 52 ...
Lasers, robots and tiny electrodes are transforming epilepsy ...
Lasers, robots and tiny electrodes are transforming epilepsy treatment : Shots - Health News For people with drug-resistant epilepsy, surgery used to be seen as a last resort. Now it's often the ...
Brain-cell transplants are the newest experimental epilepsy treatment
Graves's passion was swimming. He'd been on the high school team and had gotten certified in open-water diving. But he lost all that after his epilepsy diagnosis 17 years ago.
Pioneering Stem Cell Therapy Offers New Hope for Epilepsy Treatment
Summary: Researchers embarked on a groundbreaking clinical trial involving the injection of regenerative cells into the brain to treat epileptic seizures. This experimental therapy, called NRTX-1001, has the potential to offer drug-resistant temporal lobe epilepsy patients a non-destructive cure for their seizures.
New Trends and Most Promising Therapeutic Strategies for Epilepsy
Introduction. Epilepsy is the enduring predisposition of the brain to generate seizures, a condition that carries neurobiological, cognitive, psychological, and social consequences ().Over 50 million people worldwide are affected by epilepsy and its causes remain partially elusive, leaving physicians, and patients an unclear insight into the etiology of the disease and the best treatment ...
A Comprehensive Review of Emerging Trends and Innovative Therapies in
2.1. Challenges in Achieving Seizure Control with Traditional Therapies. Drug-resistant epilepsy represents a major clinical hurdle in epilepsy management [].Patients who are refractory to traditional ASMs face recurrent seizures that can severely impact their daily lives, disrupt social interactions, and limit educational and employment opportunities [17,18,19].
New Epilepsy Research Findings: Long-Term Outcomes with Laser Ablation
Dr. Brett Youngerman and researchers from the Columbia Comprehensive Epilepsy Center have led the largest multicenter series to date of magnetic resonance-guided laser interstitial thermal therapy (MRgLITT) recently published in the Journal of Neurology, Neurosurgery, and Psychiatry.. On the impacts of this study, Dr. Youngerman stated, "In the largest multi-center study to date, we found that ...
Forecasting May Help People with Epilepsy Predict Their Seizures
A team of epilepsy specialists at UC San Francisco has developed a method to predict 24-hour seizure risk. The discovery, which may be scalable to large numbers of patients, could help to improve the quality of life for the 2.9 million Americans living with the daily uncertainties of epilepsy.
New research reveals clues about the development of epilepsy
Traumatic brain injury is a leading cause of epilepsy, a chronic neurological disorder characterized by recurrent seizures that affects around 50 million people. A research team led by Bret Smith ...
A New Epilepsy Unit Advances Possibilities for Science and Patients at
Approximately one million people are suffering from drug-resistant epilepsy in the United States. But far fewer get surgery for the condition — only around one thousand surgeries a year — even though these procedures end seizures in around 70 percent of patients.
Focus On Epilepsy Research
The epilepsies are a set of disorders characterized by recurring seizures, or disturbances in the electrical activity of the brain. Epilepsy affects people of all ages, from infants to the aged, and can result from many causes, including genetic variations, illness, head injury, or abnormal brain development.
The 2021 Epilepsy Research Benchmarks—Respecting Core Principles
Between 2014 and the present, the Benchmarks Committee reviewed progress in each of the 4 benchmarks areas, noting remarkable discoveries across basic epilepsy research, highlighting the major gains in understanding the causes of epilepsy, but also noting many continued gaps in all areas. 9-13 We have experienced a cultural shift through which the voices of patients and advocates are not only ...
Curing the Epilepsies: The Promise of Research
Request free mailed brochure. For individuals living with a treatment-resistant form of the seizure disorders known as "the epilepsies," each day can bring debilitating seizures as well as challenges from co-occurring conditions that dramatically impair quality of life.
Epilepsy Research
Epilepsy Research provides for publication of high quality articles in both basic and clinical epilepsy research, with a special emphasis on translational research that ultimately relates to epilepsy as a human condition. The journal is intended to provide a forum for reporting the best and most … View full aims & scope $2940
Research & Funding
About Our Research & Funding . As part of our mission, we make sure the brightest new researchers become involved in epilepsy research. With the help of our partners, our investments in new therapies are bringing better treatments to people living with epilepsy.
New device for drug-resistant focal epilepsy available on NHS
A 'brain pacemaker' aiming to reduce seizures in people with drug-resistant focal epilepsy is now available on the NHS. The device is called EASEE (Epicranial Application of Stimulation Electrodes for Epilepsy) and is developed by medical technology company Precisis. EASEE is placed just under ...
Prescribing Epilepsy Meds in Pregnancy: 'We Can Do Better'
Telemedicine for Epilepsy Care a Win-Win; Anticoagulants Safe With Enzyme-Inducing Meds for Epilepsy; New, Updated Guidelines for Comprehensive Epilepsy Care
University of Virginia research provides better understanding of ...
The new UVA research found that these nets play a critical function as barriers that allow for neurons to communicate correctly. When they were disrupted in lab mice, it resulted in seizures ...
Sexual and gender minorities are twice as likely to report active epilepsy
Sexual and gender minorities (SGM)—individuals who identify as gay, lesbian, bisexual, queer, transgender, non-binary, or gender-diverse—are twice as likely to report active epilepsy compared ...
Prevalence of Epilepsy in People of Sexual and Gender Minoritized
Key Points. Question What is the prevalence of epilepsy in the sexual and gender minoritized population in the United States, and how does it compare with the prevalence of epilepsy in heterosexual, cisgender individuals?. Findings This cross-sectional study found that the prevalence of active epilepsy was 1.2% in heterosexual, cisgender people and 2.4% in people of sexual and gender ...
Seizures and Epilepsy: An Overview for Neuroscientists
This article provides an overview of seizures and epilepsy for neuroscientists. We focus on broad concepts, rather than clinical details, and raise questions related to mechanisms, epileptogenesis, and therapeutic approaches that might generate interest among basic researchers.
IMAGES
VIDEO
COMMENTS
In 2022, epilepsy research has made advances across a range of clinically important areas, from self-management, genetics, imaging, and surgical planning to understanding febrile seizures and coma-related periodic patterns. Most notably, in May 2022, the World Health Assembly adopted the Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders, which aims to address gaps ...
May 29, 2024 — While older drugs for epilepsy, taken while pregnant, have been shown in previous research to affect the creative thinking of children, a new study finds no effects on creativity ...
The research, published today in Nature Genetics, greatly advances our knowledge of why epilepsy develops and may inform the development of new treatments for the condition.. Epilepsy, a common ...
With great anticipation, 2023 has seen many important advances in epilepsy research. Noteworthy progress has been achieved in understanding the intricate mechanisms of epilepsy, accompanied by important strides in developing new therapies.
Epilepsy is one of the most common and disabling brain disorders, affecting approximately 1% of the population of all ages 1, equating to ~3.3 million people in the USA and 70 million worldwide ...
In cases where standard therapies fail, a medication called XEN1101 reduces seizure frequency by more than 50% in some patients and sometimes eliminates them altogether, a new study shows. Unlike ...
Researchers find that a little-understood part of the brain appears to be involved in starting seizures and keeping them going. April 17, 2024 - By Kimberlee D'Ardenne
New Tech Targets Epileptic Seizures With Lasers, Robots And Precision Surgery : Short Wave About three million people in the United States have epilepsy, including about a million who can't rely ...
Epilepsy refers to a group of neurological disorders of varying aetiology, characterized by recurrent brain dysfunction that result from sudden excessive and disordered neuronal discharge. These ...
The new study, performed by Dianalee McKnight and colleagues and published in JAMA Neurology, included 418 participants with epilepsy who received a genetic diagnosis between the ages of 0 and 52 ...
Lasers, robots and tiny electrodes are transforming epilepsy treatment : Shots - Health News For people with drug-resistant epilepsy, surgery used to be seen as a last resort. Now it's often the ...
Graves's passion was swimming. He'd been on the high school team and had gotten certified in open-water diving. But he lost all that after his epilepsy diagnosis 17 years ago.
Summary: Researchers embarked on a groundbreaking clinical trial involving the injection of regenerative cells into the brain to treat epileptic seizures. This experimental therapy, called NRTX-1001, has the potential to offer drug-resistant temporal lobe epilepsy patients a non-destructive cure for their seizures.
Introduction. Epilepsy is the enduring predisposition of the brain to generate seizures, a condition that carries neurobiological, cognitive, psychological, and social consequences ().Over 50 million people worldwide are affected by epilepsy and its causes remain partially elusive, leaving physicians, and patients an unclear insight into the etiology of the disease and the best treatment ...
2.1. Challenges in Achieving Seizure Control with Traditional Therapies. Drug-resistant epilepsy represents a major clinical hurdle in epilepsy management [].Patients who are refractory to traditional ASMs face recurrent seizures that can severely impact their daily lives, disrupt social interactions, and limit educational and employment opportunities [17,18,19].
Dr. Brett Youngerman and researchers from the Columbia Comprehensive Epilepsy Center have led the largest multicenter series to date of magnetic resonance-guided laser interstitial thermal therapy (MRgLITT) recently published in the Journal of Neurology, Neurosurgery, and Psychiatry.. On the impacts of this study, Dr. Youngerman stated, "In the largest multi-center study to date, we found that ...
A team of epilepsy specialists at UC San Francisco has developed a method to predict 24-hour seizure risk. The discovery, which may be scalable to large numbers of patients, could help to improve the quality of life for the 2.9 million Americans living with the daily uncertainties of epilepsy.
Traumatic brain injury is a leading cause of epilepsy, a chronic neurological disorder characterized by recurrent seizures that affects around 50 million people. A research team led by Bret Smith ...
Approximately one million people are suffering from drug-resistant epilepsy in the United States. But far fewer get surgery for the condition — only around one thousand surgeries a year — even though these procedures end seizures in around 70 percent of patients.
The epilepsies are a set of disorders characterized by recurring seizures, or disturbances in the electrical activity of the brain. Epilepsy affects people of all ages, from infants to the aged, and can result from many causes, including genetic variations, illness, head injury, or abnormal brain development.
Between 2014 and the present, the Benchmarks Committee reviewed progress in each of the 4 benchmarks areas, noting remarkable discoveries across basic epilepsy research, highlighting the major gains in understanding the causes of epilepsy, but also noting many continued gaps in all areas. 9-13 We have experienced a cultural shift through which the voices of patients and advocates are not only ...
Request free mailed brochure. For individuals living with a treatment-resistant form of the seizure disorders known as "the epilepsies," each day can bring debilitating seizures as well as challenges from co-occurring conditions that dramatically impair quality of life.
Epilepsy Research provides for publication of high quality articles in both basic and clinical epilepsy research, with a special emphasis on translational research that ultimately relates to epilepsy as a human condition. The journal is intended to provide a forum for reporting the best and most … View full aims & scope $2940
About Our Research & Funding . As part of our mission, we make sure the brightest new researchers become involved in epilepsy research. With the help of our partners, our investments in new therapies are bringing better treatments to people living with epilepsy.
A 'brain pacemaker' aiming to reduce seizures in people with drug-resistant focal epilepsy is now available on the NHS. The device is called EASEE (Epicranial Application of Stimulation Electrodes for Epilepsy) and is developed by medical technology company Precisis. EASEE is placed just under ...
Telemedicine for Epilepsy Care a Win-Win; Anticoagulants Safe With Enzyme-Inducing Meds for Epilepsy; New, Updated Guidelines for Comprehensive Epilepsy Care
The new UVA research found that these nets play a critical function as barriers that allow for neurons to communicate correctly. When they were disrupted in lab mice, it resulted in seizures ...
Sexual and gender minorities (SGM)—individuals who identify as gay, lesbian, bisexual, queer, transgender, non-binary, or gender-diverse—are twice as likely to report active epilepsy compared ...
Key Points. Question What is the prevalence of epilepsy in the sexual and gender minoritized population in the United States, and how does it compare with the prevalence of epilepsy in heterosexual, cisgender individuals?. Findings This cross-sectional study found that the prevalence of active epilepsy was 1.2% in heterosexual, cisgender people and 2.4% in people of sexual and gender ...
This article provides an overview of seizures and epilepsy for neuroscientists. We focus on broad concepts, rather than clinical details, and raise questions related to mechanisms, epileptogenesis, and therapeutic approaches that might generate interest among basic researchers.